Cash Flow Innovative Pharmaceutical Biotech Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
98.00
-254.00
36.00
-212.00
-228.00
-260.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
4.00
1.00
9.00
-6.00
-5.00
-10.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-8.00
-17.00
-12.00
-25.00
-36.00
-54.00
Cash Flow from Investing Activities
0.00
0.00
0.00
0.00
50.00
10.00
Cash Flow from Financing Activities
10.00
14.00
7.00
10.00
-9.00
40.00
Net Cash Inflow / Outflow
1.00
-2.00
-4.00
-13.00
5.00
-3.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
1.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Innovative Pharmaceutical Biotech Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
98.707
-203.491467656594
301.00
148.51%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
4.279
548.488241669964
-544.00
-99.22%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-8.279
542.173722011218
-550.00
-101.53%
Cash Flow from Investing Activities
0
-180.309677680008
180.00
100.00%
Cash Flow from Financing Activities
10.321
-461.396877296956
471.00
102.24%
Net Cash Inflow / Outflow
1.744
-98.4464406755561
99.00
101.77%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.298
1.0863922901894
-1.00
-127.43%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is 53.07% vs -43.01% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
-8.28
-17.64
53.07%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
